You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 18, 2024

Litigation Details for Finjan, Inc. v. Rapid7, Inc. (D. Del. 2018)

✉ Email this page to a colleague

« Back to Dashboard

Finjan, Inc. v. Rapid7, Inc. (D. Del. 2018)

Docket	⤷ Try a Trial	Date Filed	2018-10-01
Court	District Court, D. Delaware	Date Terminated
Cause	35:1 Patent Infringement	Assigned To	Maryellen Noreika
Jury Demand	Plaintiff	Referred To
Parties	FINJAN, INC.; RAPID7 LLC; RAPID7, INC.
Patents	10,004,237; 10,004,729; 10,005,847; 10,010,508; 10,010,585; 10,016,385; 10,023,892; 10,031,141; 10,071,170; 10,118,901; 10,385,062; 10,385,135; 10,386,359; 10,406,006; 10,449,118; 10,478,478; 10,478,601; 10,493,094; 10,493,303; 10,501,538; 10,585,088; 6,024,657; 6,264,984; 6,359,016; 6,565,449; 6,602,657; 6,610,830; 6,830,253; 6,844,390; 6,858,650; 6,951,844; 6,984,518; 7,008,397; 7,014,610; 7,014,990; 7,128,658; 7,138,546; 7,141,018; 7,141,237; 7,345,014; 7,381,141; 7,449,012; 7,585,493; 7,598,089; 7,611,702; 7,619,004; 7,847,061; 7,858,118; 7,892,547; 7,892,563; 8,007,381; 8,012,480; 8,017,390; 8,062,264; 8,071,546; 8,222,015; 8,222,219; 8,383,610; 8,383,890; 8,404,215; 8,404,702; 8,449,886; 8,460,101; 8,460,381; 8,466,128; 8,501,730; 8,502,026; 8,518,390; 8,518,886; 8,563,008; 8,563,493; 8,602,215; 8,715,118; 8,729,019; 8,729,094; 9,002,657; 9,005,619; 9,006,222; 9,006,223; 9,006,259; 9,012,508; 9,023,397; 9,101,585; 9,302,002; 9,364,493; 9,381,243; 9,402,901; 9,404,118; 9,408,858; 9,408,979; 9,517,023; 9,517,219; 9,598,711; 9,602,858; 9,650,611; 9,657,003; 9,657,012; 9,732,062; 9,890,189; 9,951,016
Attorneys	Aaron M. Frankel; David C. Dotson; Hannah Lee; Jarrad M. Gunther; Jennifer H. Forte; John R. Gibson; Jonathan A. Choa; Jordana A. Garellek; L. Norwood Jameson; Lisa Kobialka; Matthew C. Gaudet; Paul J. Andre; Philip A. Rovner; Rachael D. Lamkin; Richard L. Renck; Robin McGrath
Firms	Duane Morris, LLP
Link to Docket	External link to docket

Small Molecule Drugs cited in Finjan, Inc. v. Rapid7, Inc.

The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .

Biologic Drugs cited in Finjan, Inc. v. Rapid7, Inc.

The biologic drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .

Details for Finjan, Inc. v. Rapid7, Inc. (D. Del. 2018)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Date Filed	Document No.	Description	Snippet	Link To Document
2020-05-11	136	Exhibit to a Document	Telephone: 650.847.4146 5 12390 El Camino Real, Suite 100 Facsimile: 650.847.4151 …Telephone: 650.847.4146 7 Facsimile: 650.847.4151 8 …background, 2706 08.05.2014 email from Ivan Chaperot regarding security patent landscape … 05/11/20 Page 10 ofPage 5 of 83#: 6092 …from Sally Gillis to Yuval Ben Itzhak regarding patent enforcement project	External link to document
2020-05-18	140	Redacted Document	DIRECT DIAL: +1 302 657 4906 E-MAIL: RLRenck…involving two of the same asserted patents and two other related patents. Finjan has produced these transcripts…Cisco was an investor in Finjan did not involve patent matters. Ex. B, at 64:2-65:13; 68:12- 16 ( … to. Further, any interest in Finjan’s patent litigation plans that Cisco had as an investor …same interest in obtaining strong and enforceable patents” existed). Likewise, “Plaintiffs have not identified	External link to document
2020-05-19	141	Exhibit 1-4	citing United States v. Schwimmer, 892 F.2d 237, 243 (2nd Cir. 1989)). We hold that…rights or interest in enforcement of the patent or management of the litigation.” Tr. 21 (Nov. … with Raptor, namely the validity of the patent, protects the disclosure from waiver. We … the legal g status of the ‘460 patent p …and other legal questions concerning the patent. 3 B. SecurityPoint Employees and	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.